NLRP3 and endometrial cancer: It has been found that the activation of NLRP3 plays a role in many chronic inflammatory diseases, and molecular H2 can effectively inhibit the activation of NLRP3 to ameliorate endometrial cancer [8], kidney inflammation [48], septicemia [49], neuropathic pain [50], and so on.